Safety and therapeutic effects of anti-fibrotic Traditional Chinese Medicine Fuzheng Huayu on persistent advanced stage fibrosis following 2 years entecavir treatment: Study protocol for a single arm clinical objective performance criteria trial
Author:
Funder
National Science and Technology
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference22 articles.
1. Hepatitis: long-term therapy of chronic hepatitis B reverses cirrhosis;Lok;Nat. Rev. Gastroenterol. Hepatol.,2013
2. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study;Marcellin;Lancet,2013
3. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group;Lai;N. Engl. J. Med.,1998
4. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years;Hadziyannis;Gastroenterology,2006
5. Clinical trial: effects of adefovir dipivoxil therapy in Asian and Caucasian patients with chronic hepatitis B;Lim;Aliment. Pharmacol. Ther.,2007
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Research progress of traditional Chinese medicine in improving hepatic fibrosis based on inhibiting pathological angiogenesis;Frontiers in Pharmacology;2023-12-12
2. Chinese herbal formula ruangan granule enhances the efficacy of entecavir to reverse advanced liver fibrosis/early cirrhosis in patients with chronic HBV infection: A multicenter, randomized clinical trial;Pharmacological Research;2023-04
3. Multi-component Chinese medicine formulas for drug discovery: State of the art and future perspectives;Acta Materia Medica;2023
4. Efficacy and safety of Fuzheng Huayu tablet on persistent advanced liver fibrosis following 2 years entecavir treatment: A single arm clinical objective performance criteria trial;Journal of Ethnopharmacology;2022-11
5. Gynostemma pentaphyllum polysaccharides ameliorate non-alcoholic steatohepatitis in mice associated with gut microbiota and the TLR2/NLRP3 pathway;Frontiers in Endocrinology;2022-07-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3